{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:01:39Z","timestamp":1792659699518,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.clon.2012.02.010","type":"journal-article","created":{"date-parts":[[2012,4,2]],"date-time":"2012-04-02T08:46:15Z","timestamp":1333356375000},"page":"345-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Lymphoma of the Thyroid and Head and Neck"],"prefix":"10.1016","volume":"24","author":[{"given":"M.J.","family":"Beasley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2012.02.010_bib1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.clon.2003.10.010","article-title":"Localised extranodal lymphoma of the head and neck: the Sheffield Lymphoma Group experience (1971\u20132000)","volume":"16","author":"Hart","year":"2004","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.010_bib2","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1002\/cncr.25138","article-title":"Hodgkin's lymphoma involving extranodal and head and neck sites","volume":"35","author":"Iyengar","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2012.02.010_bib3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0360-3016(85)90158-0","article-title":"Non-Hodgkin's lymphoma of head and neck extranodal sites","volume":"11","author":"Jacobs","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2012.02.010_bib4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00277-004-0860-0","article-title":"Treatment results of tonsillar lymphoma: a 10 year experience","volume":"84","author":"Mohammadianpanah","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clon.2012.02.010_bib5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1159\/000227097","article-title":"Primary extranodal non-Hodgkin's lymphoma of the head and neck","volume":"49","author":"Economopoulos","year":"1992","journal-title":"Oncology"},{"key":"10.1016\/j.clon.2012.02.010_bib6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.clon.2008.05.007","article-title":"Non-Hodgkin's lymphoma of Waldeyer's ring in children: outcome using chemotherapy and involved field radiotherapy","volume":"20","author":"Laskar","year":"2008","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.010_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0964-1955(95)00058-5","article-title":"Treatment of non-Hodgkin's lymphoma of Waldeyer's ring: radiotherapy versus chemotherapy versus combined therapy","volume":"32B","author":"Aviles","year":"1996","journal-title":"Oral Oncol Eur J Cancer"},{"key":"10.1016\/j.clon.2012.02.010_bib8","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/cncr.22841","article-title":"Primary diffuse large B-cell lymphoma of tonsil","volume":"110","author":"Laskar","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2012.02.010_bib9","first-page":"4655","article-title":"Primary extranodal non-Hodgkin's lymphoma of the head and neck in adults: a clinicopathological comparison between tonsillar and non-tonsillar lymphomas","volume":"18","author":"Economopoulos","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clon.2012.02.010_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM199807023390104","article-title":"Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate and high-grade non-Hodgkin's lymphoma","volume":"339","author":"Miller","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2012.02.010_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"Chop chemotherapy plus rituximab compared with chop alone in elderly patients with diffuse large B cell lymphoma","volume":"346","author":"Coiffer","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2012.02.010_bib12","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1470-2045(11)70235-2","article-title":"CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large B-cell lymphoma: 6 year results of an open-label randomised study of the MabThera International Trial (MinT) Group","volume":"12","author":"Pfreundschuh","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2012.02.010_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","article-title":"Reduced dose radiotherapy for local control in non-Hodgkin's lymphoma: a randomised phase III trial","volume":"100","author":"Lowry","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2012.02.010_bib14","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ijrobp.2008.12.053","article-title":"A prospective study of salivary gland function in lymphoma patients receiving head and neck irradiation","volume":"75","author":"Rodriguez","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2012.02.010_bib15","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1200\/JCO.2007.11.5501","article-title":"Prospective randomised study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients","volume":"25","author":"Kam","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.010_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2012.02.010_bib17","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ijrobp.2006.06.013","article-title":"Xerostomia and quality of life after intensity-modulated radiotherapy vs conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial results on a randomised controlled trial","volume":"66","author":"Pow","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2012.02.010_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/COC.0b013e3181841f42","article-title":"Xerostomia in long-term survivors of aggressive non-Hodgkin's lymphoma of Waldeyer's ring","volume":"32","author":"Chang","year":"2009","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.010_bib19","first-page":"1151","article-title":"Head and neck extranodal non-Hodgkin's lymphoma: radiation therapy and chemotherapy","volume":"7","author":"Donato","year":"1995","journal-title":"Int J Oncol"},{"key":"10.1016\/j.clon.2012.02.010_bib20","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.anndiagpath.2005.09.020","article-title":"Extranodal lymphomas of the head and neck","volume":"9","author":"Vega","year":"2005","journal-title":"Ann Diag Pathol"},{"key":"10.1016\/j.clon.2012.02.010_bib21","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.ijrobp.2004.05.066","article-title":"Efficacy and treatment-related toxicity of radiotherapy for early-stage primary non-Hodgkin's lymphoma of the parotid gland","volume":"60","author":"Olivier","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2012.02.010_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/jcp.55.1.61","article-title":"Primary T cell lymphoma of the salivary gland","volume":"55","author":"Hew","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.clon.2012.02.010_bib23","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1080\/10428190701528509","article-title":"Primary salivary gland lymphoma among Japanese: a clinicopathological study of 30 cases","volume":"48","author":"Kojima","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clon.2012.02.010_bib24","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood.V91.6.1864","article-title":"Clonal salivary gland infiltrates associated with myoepithelialsialadenitis (Sjorgren's syndrome) begin as non-malignant antigen-selected expansions","volume":"6","author":"Bahler","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.clon.2012.02.010_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000081273","article-title":"Primary salivary gland lymphoma: a clinicopathologic study of 23 cases in Taiwan","volume":"112","author":"Dunn","year":"2004","journal-title":"Acta Haematol"},{"key":"10.1016\/j.clon.2012.02.010_bib26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/106689690100900405","article-title":"Follicular lymphoma of the salivary gland","volume":"9","author":"Kojima","year":"2001","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.clon.2012.02.010_bib27","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0964-1955(96)00031-0","article-title":"Marginal zone B cell lymphoma of the parotid glands: results of a randomised trial comparing radiotherapy to combined therapy","volume":"32B","author":"Aviles","year":"1996","journal-title":"Oral Oncol Eur J Cancer"},{"key":"10.1016\/j.clon.2012.02.010_bib28","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2002-04-1279","article-title":"Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue","volume":"101","author":"Zucca","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clon.2012.02.010_bib29","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/cncr.25226","article-title":"Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy","volume":"116","author":"Goda","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2012.02.010_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/CCO.0b013e3283330848","article-title":"Primary thyroid lymphoma: a review of recent developments in diagnosis and histology-driven treatment","volume":"22","author":"Graff-Baker","year":"2010","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.clon.2012.02.010_bib31","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.surg.2009.09.020","article-title":"Prognosis of primary thyroid lymphoma: demographic, clinical and pathologic predictors of survival in 1,408 cases","volume":"146","author":"Graff-Baker","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.clon.2012.02.010_bib32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1259\/bjr\/31803121","article-title":"Management of non-Hodgkin's lymphoma of the thyroid: the Royal Marsden Hospital experience","volume":"78","author":"Harrington","year":"2005","journal-title":"Br J Radiol"},{"key":"10.1016\/j.clon.2012.02.010_bib33","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/annonc\/mdm094","article-title":"Clinco-pathologic correlations of stage IE\/IIE primary thyroid diffuse large B-cell lymphoma","volume":"18","author":"Niitsu","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2012.02.010_bib34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/annonc\/mdq310","article-title":"Treatment results and prognostic factors in primary thyroid lymphoma patients: a rare cancer network study","volume":"22","author":"Onal","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2012.02.010_bib35","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3109\/10428194.2011.555888","article-title":"High response rate and improvement in long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B cell lymphoma: an International Extranodal Lymphoma Study Group and IntergruppoItalianolinfomi study","volume":"52","author":"Mian","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clon.2012.02.010_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1210\/jcem.87.1.8156","article-title":"Primary thyroid lymphoma is a heterogenous disease","volume":"87","author":"Thieblemont","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clon.2012.02.010_bib37","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2141.2011.08606.x","article-title":"Clinicopathological features of 171 cases of primary thyroid lymphoma: a long term study involving 24,553 patients with Hashimoto's disease","volume":"153","author":"Watanabe","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clon.2012.02.010_bib38","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0936-6555(05)80271-7","article-title":"The significance of MALT histology in thyroid lymphoma: a review of patients from the BNLI and the Royal Marsden Hospital","volume":"6","author":"Laing","year":"1994","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.010_bib39","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF02573069","article-title":"Primary thyroid lymphoma: can the diagnosis be made solely by fine needle aspiration?","volume":"9","author":"Cha","year":"2002","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clon.2012.02.010_bib40","first-page":"295","article-title":"Primary thyroid lymphoma: case series and literature review","volume":"14","author":"Kebapcilar","year":"2009","journal-title":"J BUON"},{"key":"10.1016\/j.clon.2012.02.010_bib41","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s00268-005-0768-z","article-title":"An evidence-based approach to the treatment of thyroid lymphoma","volume":"31","author":"Mack","year":"2007","journal-title":"World J Surg"},{"key":"10.1016\/j.clon.2012.02.010_bib42","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0167-8140(01)00382-6","article-title":"Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland","volume":"60","author":"Nutting","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2012.02.010_bib43","first-page":"352","article-title":"Current management of nasal NK\/T-cell lymphoma","volume":"24","author":"Wing","year":"2010","journal-title":"Oncology"},{"key":"10.1016\/j.clon.2012.02.010_bib44","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ijrobp.2003.12.006","article-title":"Angiocentric T-cell and NK\/T-cell lymphomas: radiotherapeutic viewpoints","volume":"59","author":"Koom","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2012.02.010_bib45","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1365-2141.2005.05387.x","article-title":"Incidence and spectrum of non-Hodgkin's lymphoma in Chinese migrants to British Columbia","volume":"128","author":"Au","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clon.2012.02.010_bib46","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0360-3016(02)02916-4","article-title":"Early stage nasal NK\/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality","volume":"54","author":"Cheung","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2012.02.010_bib47","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijrobp.2007.05.073","article-title":"Early or up-front radiotherapy improved survival of localised extranodal NK\/T-cell lymphoma, nasal type in the upper aerodigestive tract","volume":"70","author":"Huang","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2012.02.010_bib48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2141.2009.07802.x","article-title":"Advances in the management and monitoring of extranodal NK\/T-cell lymphoma, nasal type","volume":"147","author":"Liang","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clon.2012.02.010_bib49","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/cncr.21656","article-title":"Extranodal natural killer\/T-cell lymphoma, nasal type. The significance of radiotherapeutic parameters","volume":"106","author":"Isobe","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2012.02.010_bib50","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2214\/ajr.174.4.1741141","article-title":"Nasal T\/NK cell lymphoma: CT and MR imaging features of a new clinico-pathological entity","volume":"174","author":"Ooi","year":"2000","journal-title":"Am J Roetgenol"},{"key":"10.1016\/j.clon.2012.02.010_bib51","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00277-008-0494-8","article-title":"Flourine-18 flurodeoxyglucose\u00a0positron emission tomography in mature T-cell and\u00a0natural killer cell malignancies","volume":"87","author":"Khong","year":"2008","journal-title":"Ann Haematol"},{"key":"10.1016\/j.clon.2012.02.010_bib52","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s12032-009-9288-7","article-title":"Treatment outcome of radiotherapy alone versus radio-chemotherapy in early stage nasal natural killer\/T-cell lymphoma","volume":"27","author":"Ma","year":"2010","journal-title":"Med Oncol"},{"key":"10.1016\/j.clon.2012.02.010_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jjco\/hyi006","article-title":"Treatment outcome of angiocentric T-cell and NK\/T-cell lymphoma nasal type: radiotherapy versus chemoradiotherapy","volume":"35","author":"Kim","year":"2005","journal-title":"Japan J Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.010_bib54","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/annonc\/mdh143","article-title":"Radiation therapy versus chemotherapy as initial treatment for localised nasal natural killer (NK)\/T cell lymphoma: a single institution survey in Taiwan","volume":"15","author":"You","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2012.02.010_bib55","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.clon.2008.05.011","article-title":"A clinical study of 115 patients with extranaodal natural killer\/T-cell lymphoma, nasal type","volume":"20","author":"Wu","year":"2008","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.010_bib56","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s12185-010-0720-8","article-title":"Treatment of localized extranodal NK\/T-cell lymphoma","volume":"92","author":"Kim","year":"2010","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clon.2012.02.010_bib57","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1349-7006.2008.00768.x","article-title":"Phase 1 study of dexamethasone, methotrexate, ifosphamide. L-asparaginase and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory natural killer (NK)\/T-cell lymphoma and leukaemia","volume":"99","author":"Yamaguchi","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.clon.2012.02.010_bib58","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1200\/JCO.2009.23.8592","article-title":"Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK\/T-cell lymphoma: consortium for improving survival of lymphoma study","volume":"27","author":"Kim","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.010_bib59","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/annonc\/mdp412","article-title":"When do we need central nervous system prophylaxis in patients with extranodal NK\/T-cell lymphoma nasal type?","volume":"21","author":"Kim","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2012.02.010_bib60","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ijrobp.2011.02.039","article-title":"Mild toxicity and favourable prognosis of high-dose and extended involved-field intensity modulated radiotherapy for patients with early stage nasal NK\/T-cell lymphoma","volume":"82","author":"Wang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655512000714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655512000714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:37:26Z","timestamp":1760542646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655512000714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0936655512000714"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2012.02.010","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphoma of the Thyroid and Head and Neck","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2012.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}